Injectable cartilage matrix hydrogel loaded with cartilage endplate stem cells engineered to release exosomes for non-invasive treatment of intervertebral disc degeneration
Liwen Luo,Junfeng Gong,Zhouguang Wang,Yao Liu,Jiaming Cao,Jinghao Qin,Rui Zuo,Hongyu Zhang,Shuai Wang,Ping Zhao,Di Yang,Mengjie Zhang,Yanqiu Wang,Junfeng Zhang,Yue Zhou,Changqing Li,Bing Ni,Zhiqiang Tian,MingHan Liu
DOI: https://doi.org/10.1016/j.bioactmat.2021.12.007
IF: 18.9
2022-09-01
Bioactive Materials
Abstract:Low back pain, mainly caused by intervertebral disc degeneration (IVDD), is a common health problem; however, current surgical treatments are less than satisfactory. Thus, it is essential to develop novel non-invasive surgical methods for IVDD treatment. Here, we describe a therapeutic strategy to inhibit IVDD by injecting hydrogels modified with the extracellular matrix of costal cartilage (ECM-Gels) that are loaded with cartilage endplate stem cells (CESCs). After loaded with CESCs overexpressing Sphk2 (Lenti-Sphk2-CESCs) and injected near the cartilage endplate (CEP) of rats in vivo, ECM-Gels produced Sphk2-engineered exosomes (Lenti-Sphk2-Exos). These exosomes penetrated the annulus fibrosus (AF) and transported Sphk2 into the nucleus pulposus cells (NPCs). Sphk2 activated the phosphatidylinositol 3-kinase (PI3K)/p-AKT pathway as well as the intracellular autophagy of NPCs, ultimately ameliorating IVDD. This study provides a novel and efficient non-invasive combinational strategy for IVDD treatment using injectable ECM-Gels loaded with CESCs that express Sphk2 with sustained release of functional exosomes.
engineering, biomedical,materials science, biomaterials